Authorized Generic Pharmaceuticals: Effects on Innovation

Thomas, John R

Library of Congress. Congressional Research Service.

关键词: Medicine;    Competition;    Drug industry;    Generic drugs;    Business;   

RP-ID  :  RL33605
RP-ID  :  RL33605 2006-08-08

美国|英语

来源: UNT Digital Library

【 摘 要 】

The practice of “authorized generics” has recently been the subject of considerable attention by the pharmaceutical industry, regulators, and members of Congress alike. An “authorized generic”–sometimes termed a “branded,” “flanking,” or “pseudo” generic–is a pharmaceutical that is marketed by or on behalf of a brand name drug company, but is sold under a generic name. Although the availability of an additional competitor in the generic drug market would appear to be favorable to consumers, authorized generics have nonetheless proven controversial. Some observers believe that authorized generics potentially discourage independent generic firms both from challenging drug patents and from selling their own products.